SIGNUP FOR
NEWSLETTER
TSX: HSM
NASDAQ: HSDT
Call us: +1 877-564-0008
About
Back
Overview
Meet Our Team
Advisory Board
Scientific Interests
Divisions
Back
Overview
Helius Medical
Back
The PoNS Device
Investor Relations
Back
Overview
Stock Info
Events
Back
Upcoming Events
Past Events
Code of Conduct
Corporate Documents
Committee Charters
SEC Filings
Financial Information
Investor FAQ
Newsroom
Back
News Releases
Back
2021
2020
2019
2018
Archive
Back
2017
2016
2015
2014
In the News
Back
HMT Coverage
Related Science
Media Resources
Our Research
Back
Overview
Clinical Trials
Peer-Reviewed Publications
Words to Know
Research Partners
Contact
Back
Contact HMT
Subscribe Newsletter
Careers
Back
Home
Newsroom
News Releases
Menu
News Releases
2021
2020
2019
2018
Archive
2017
2016
2015
2014
In the News
HMT Coverage
Related Science
Media Resources
Stock Quote - HSM-T
*Delayed quote courtesy of Google.
Stock Quote - HSDT
*Delayed quote courtesy of Google.
2021 News
Filters
- Select Tag -
Clinical News
Corporate News
Filter
List of articles in category 2021 News
Title
Date
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
15 Apr, 2021
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
07 Apr, 2021
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
29 Mar, 2021
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd
17 Mar, 2021
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors
17 Mar, 2021
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
10 Mar, 2021
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
02 Feb, 2021
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
01 Feb, 2021
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
28 Jan, 2021
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
20 Jan, 2021
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards
19 Jan, 2021
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference
15 Jan, 2021
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
11 Jan, 2021
Helius Medical Technologies, Inc. Comments on Unusual Market Activity
05 Jan, 2021
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
04 Jan, 2021
